(GSK) GlaxoSmithKline - Performance 4.9% in 12m
GSK performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
43.89%
#21 in Peer-Group
Rel. Strength
47.78%
#3973 in Stock-Universe
Total Return 12m
4.92%
#68 in Peer-Group
Total Return 5y
57.73%
#29 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | 19.9 |
| P/E Forward | 9.20 |
| High / Low | USD |
|---|---|
| 52 Week High | 42.79 USD |
| 52 Week Low | 31.37 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 66.31 |
| Buy/Sell Signal +-5 | -2.05 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: GSK (4.9%) vs XLV (-5.1%)
5y Drawdown (Underwater) Chart
Top Performer in Pharmaceuticals
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| CORT NASDAQ Corcept Therapeutics |
-4.5% | 145% | 360% | 61.3 | 55.3 | 0.61 | 23.7% | -5.15% |
| LLY NYSE Eli Lilly |
12% | -6.78% | 514% | 66.1 | 37 | 1.24 | 58.2% | 18.9% |
| NVS NYSE Novartis |
10.1% | 17.9% | 81.6% | 18.5 | 14 | 1.37 | 8.70% | 9.2% |
| NOVN SW Novartis |
7.55% | 7.58% | 54.8% | 18.7 | 14.1 | 1.38 | 9.80% | 11.2% |
| SFZN SW Siegfried Holding |
-0.63% | 2.28% | 140% | 26.1 | 25 | 1.48 | 77.8% | 77.6% |
| GSK NYSE GlaxoSmithKline |
10% | 4.92% | 57.7% | 19.9 | 9.2 | 0.4 | -25.2% | 3.11% |
| AZN NASDAQ AstraZeneca |
9.51% | -4.27% | 58.6% | 28.9 | 15.9 | 0.96 | 52.7% | 22.3% |
| IPN PA Ipsen |
2.14% | -13% | 54.2% | 24.4 | 10.3 | 0.74 | -6.40% | -6.33% |
Performance Comparison: GSK vs XLV vs S&P 500
XLV (Health Care Sector SPDR ETF) is the Sector Benchmark for GSK
| Total Return (including Dividends) | GSK | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | 10.01% | 4.35% | 1.11% |
| 3 Months | 2.69% | -6.89% | 5.58% |
| 12 Months | 4.92% | -5.08% | 10.51% |
| 5 Years | 57.73% | 50.53% | 109.12% |
| Trend Score (consistency of price movement) | GSK | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | 89.4% | 65.8% | 69.9% |
| 3 Months | 46.6% | -72% | 69.3% |
| 12 Months | -13.3% | -62.2% | 43.2% |
| 5 Years | 90.5% | 88.5% | 84.1% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XLV | vs. S&P 500 |
|---|---|---|---|
| 1 Month | #60 | 5.43% | 8.81% |
| 3 Month | #75 | 10.29% | -2.74% |
| 12 Month | #68 | 10.54% | -5.06% |
| 5 Years | #33 | 4.78% | -24.57% |
FAQs
Does GlaxoSmithKline (GSK) outperform the market?
Yes,
over the last 12 months GSK made 4.92%, while its related Sector, the Health Care Sector SPDR (XLV) made -5.08%.
Over the last 3 months GSK made 2.69%, while XLV made -6.89%.
Performance Comparison GSK vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
GSK vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 0.5% | 8.9% | 25.4% | -6% |
| US NASDAQ 100 | QQQ | 0.7% | 8.5% | 26.2% | -4% |
| German DAX 40 | DAX | 2.7% | 10.8% | 9.1% | -25% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 0.7% | 10.9% | 23.6% | -7% |
| Hongkong Hang Seng | HSI | -0.1% | 5% | 6.4% | -23% |
| India NIFTY 50 | INDA | 2.2% | 11.3% | 26.5% | 6% |
| Brasil Bovespa | EWZ | -1.9% | 9.6% | 5.2% | -4% |
GSK vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 0.8% | 8.5% | 22.6% | -18% |
| Consumer Discretionary | XLY | 1% | 11.8% | 35.3% | -13% |
| Consumer Staples | XLP | 0.8% | 10.2% | 24% | -2% |
| Energy | XLE | -5.4% | 7.1% | 21.8% | 2% |
| Financial | XLF | 2% | 12.6% | 22.6% | -19% |
| Health Care | XLV | -1.5% | 5.7% | 25.9% | 10% |
| Industrial | XLI | 1.5% | 9.7% | 19.9% | -13% |
| Materials | XLB | 1.1% | 8.6% | 24.7% | 6% |
| Real Estate | XLRE | -0.1% | 9.1% | 24.4% | -8% |
| Technology | XLK | 0.2% | 8% | 25% | 1% |
| Utilities | XLU | -0.9% | 9.5% | 17.1% | -16% |
| Aerospace & Defense | XAR | 1.5% | 4.2% | 8.5% | -38% |
| Biotech | XBI | 0.8% | 2.3% | 36.2% | 13% |
| Homebuilder | XHB | 2.1% | 15% | 40.9% | 14% |
| Retail | XRT | 4.4% | 10.2% | 33.4% | 4% |
GSK vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | -11.3% | -8.68% | 15.6% | 2% |
| Natural Gas | UNG | 1.2% | 12.6% | 7.2% | 20% |
| Gold | GLD | -3.2% | 3.8% | -4.7% | -42% |
| Silver | SLV | 1.3% | -1.3% | 5.8% | -18% |
| Copper | CPER | 3% | 8.3% | 10.6% | -3% |
GSK vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | -1% | 9.3% | 26.9% | 9% |
| iShares High Yield Corp. Bond | HYG | -0% | 9.5% | 21.8% | -4% |